About John Yu
John Yu is CEO and Chairman at Kairos Pharma.
John Yu reports to the SEC as a director, officer or major shareholder of 2 public companies, including ImmunoCellular Therapeutics (IMUC).
John Yu first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name John Yu in the role, so the role may have started earlier or lasted longer.
IL
ImmunoCellular Therapeutics, Ltd.
Secretary and director
2012 – 2018 · Public company (IMUC)
Key Colleagues at Startups
The people John Yu works with at each company, as listed on that company's latest Form D.
Kairos Pharma, LTD. · Form D, Jan 28, 2025
HB
Hyun Bae
Independent Director
NB
Neil Bhowmick
Chief Scientific Officer
HK
Hansoo Michael Keyoung
Independent Director
RM
Ramachandran Murali
Vice President of Research and Development
DS
Doug Samuelson
Chief Financial Officer
RS
Rahul Singhvi
Independent Director